Synthesis and biological evaluation of naphthoquinone analogs as a novel class of proteasome inhibitors.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2010-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2010.06.038PMID 20621484PMCID PMC3530924
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Snapshots of the fluorosalinosporamide/20S complex offer mechanistic insights for fine tuning proteasome inhibition.

  2009cited by this paper
• Discovery and development of the anticancer agent salinosporamide A (NPI-0052).

  2009cited by this paper
• Discovery of a novel proteasome inhibitor selective for cancer cells over non-transformed cells

  2009cited by this paper
• The potential of proteasome inhibitors in cancer therapy

  2008cited by this paper
• Development of proteasome inhibitors in oncology and autoimmune diseases.

  2008cited by this paper
• Proteasome Inhibitors in Cancer Therapy: Lessons from the First Decade

  2008cited by this paper
• Proteasome inhibitors: a therapeutic strategy for haematological malignancy.

  2008cited by this paper
• Alternative UPS drug targets upstream the 26S proteasome.

  2008cited by this paper
• The ubiquitin-proteasome system: A novel target for anticancer and anti-inflammatory drug research

  2008cited by this paper
• CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib.

  2008cited by this paper
• Patented small molecule inhibitors in the ubiquitin proteasome system

  2007cited by this paper
• Corrigendum to “Analgesic agents without gastric damage: Design and synthesis of structurally simple benzenesulfonanilide-type cyclooxygenase-1-selective inhibitors” [Bioorg. Med. Chem. 15 (2007) 1014–1021]

  2007cited by this paper
• Epik: a software program for pKa prediction and protonation state generation for drug-like molecules

  2007cited by this paper
• Analgesic agents without gastric damage: design and synthesis of structurally simple benzenesulfonanilide-type cyclooxygenase-1-selective inhibitors.

  2007cited by this paper
• Drug discovery in the ubiquitin–proteasome system

  2006cited by this paper
• A Multicenter Retrospective Analysis of Adverse Events in Korean Patients Using Bortezomib for Multiple Myeloma

  2006cited by this paper
• Highly specific N-monomethylation of primary aromatic amines

  2006cited by this paper
• Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome.

  2006cited by this paper
• A novel proteasome inhibitor NPI-0052 as an anticancer therapy

  2006cited by this paper
• Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

  2006cited by this paper
• Importance of accurate charges in molecular docking: Quantum mechanical/molecular mechanical (QM/MM) approach

  2005cited by this paper
• Proteasome: an emerging target for cancer therapy

  2005cited by this paper
• Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity.

  2005cited by this paper
• Solid-phase synthesis of 2-amino-3-chloro-5- and 8-nitro-1,4-naphthoquinones: a new and general colorimetric test for resin-bound amines

  2005cited by this paper
• Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma.

  2005cited by this paper
• The proteasome: a suitable antineoplastic target

  2004cited by this paper
• The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications.

  2004cited by this paper
• Cell cycle, proteolysis and cancer.

  2004cited by this paper
• Proteasome inhibition with PS-341 (bortezomib) in lung cancer therapy.

  2004cited by this paper
• Discovery, Development, and clinical applications of bortezomib.

  2004cited by this paper
• Proteasomes as drug targets.

  2003cited by this paper
• The proteasome as a target for cancer therapy.

  2003cited by this paper
• Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein.

  2003cited by this paper
• Novel 4,1-benzoxazepine derivatives with potent squalene synthase inhibitory activities.

  2002cited by this paper
• Synthesis and PTP1B inhibition of 1,2-naphthoquinone derivatives as potent anti-diabetic agents.

  2002cited by this paper
• Potent reversible inhibitors of the protein tyrosine phosphatase CD45.

  2001cited by this paper
• Proteasome inhibition in cancer: development of PS-341.

  2001cited by this paper
• Synthesis of 8-methoxy-1-methyl-1H-benzo[de][1,6]naphthyridin-9-ol (Isoaaptamine) and analogues.

  2000cited by this paper
• Structure of 20S proteasome from yeast at 2.4Å resolution

  1997cited by this paper
• Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics

  1990cited by this paper
• The Protein Data Bank: a computer-based archival file for macromolecular structures.

  1977cited by this paper
• Synthese N7-alkylierter 7-Aminosulfonyl-6-trifluormethyl-2,3-dihydro-4H-1,2,4-benzothiadiazin-1,1-dioxyde.

  1962cited by this paper
• [Some sulfanilamides].

  1950cited by this paper
• The Preparation of Amine Derivatives of 2-Chloro-1,4-naphthoquinone

  1950cited by this paper

• Inhibitors of the 20S proteasome β5 subunit as potent and selective agents against Trichomonas vaginalis

  2025cites this paper
• Grüner Tee – Daten und Studien zur chinesischen und westlichen Wirkung

  2024cites this paper
• Selective N-Alkylation of Aminobenzenesulfonamides with Alcohols for the Synthesis of Amino-(N-alkyl)benzenesulfonamides Catalyzed by a Metal-Ligand Bifunctional Ruthenium Catalyst.

  2024cites this paper
• Visible light-driven and substrate-promoted alkenyltrifluoromethylation of alkenes to synthesize CF3-functionalized 1,4-naphthoquinones.

  2024cites this paper
• Natural products-isoxazole hybrids: A review of developments in medicinal chemistry

  2024cites this paper
• Sulfonamide derivatives: Synthesis and applications

  2024cites this paper
• Design, synthesis, and biological evaluation of some novel naphthoquinone‐glycine/β‐alanine anilide derivatives as noncovalent proteasome inhibitors

  2023cites this paper
• tert-Butylhydroperoxide mediated radical cyanoalkylation/cyanoalkenylation of 2-anilino-1,4-naphthoquinones with vinylarenes/arylalkynes and azobis(alkylcarbonitrile)s.

  2023cites this paper
• Synthesis of 4-Amino-1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)one-[1,2,3]triazolebenzenesulphonamide Bioactive Hybrids as Novel Therapeutic Agents

  2023cites this paper
• Design, Synthesis, Molecular Docking Analysis and Biological Evaluations of 4-[(Quinolin-4-yl)amino]benzamide Derivatives as Novel Anti-Influenza Virus Agents

  2022cites this paper
• Base-catalyzed monofunctionalization of N-alkyl activated azaarenes to construct 2-Iminoderivatives

  2022cites this paper
• 1,4-Naphthoquinone Motif in the Synthesis of New Thiopyrano[2,3-d]thiazoles as Potential Biologically Active Compounds

  2022cites this paper
• Sulfonamide moiety as "molecular chimera" in the design of new drugs.

  2022cites this paper
• Synthesis, Antimicrobial, Cytotoxic and Molecular Docking Studies of Bis(azolylsulfonyl)pyrrole Dicarboxamides

  2022cites this paper
• Computer-aided design of 1,4-naphthoquinone-based inhibitors targeting cruzain and rhodesain cysteine proteases.

  2021cites this paper
• Synthetic enamine naphthoquinone derived from lawsone as cytotoxic agents assessed by in vitro and in silico evaluations.

  2021cites this paper
• Discovery and structure–activity relationships of the quinolinequinones: Promising antimicrobial agents and mode of action evaluation

  2021cites this paper
• Enzyme inhibition and antioxidant potential of new synthesized sulfonamides; synthesis, single crystal and molecular docking

  2021cites this paper
• N-Methylation of Amines with Methanol in the Presence of Carbonate Salt Catalyzed by a Metal-Ligand Bifunctional Ruthenium Catalyst [(p-cymene)Ru(2,2'-bpyO)(H2O)].

  2021cites this paper
• Design, synthesis, characterization, and antimicrobial activity of novel piperazine substituted 1,4-benzoquinones

  2020cites this paper
• Design, synthesis and biological evaluation of novel naphthoquinone-4-aminobenzensulfonamide/carboxamide derivatives as proteasome inhibitors.

  2020cites this paper
• Ubiquitination in rheumatoid arthritis.

  2020cites this paper
• Brominated plastoquinone analogs: Synthesis, structural characterization, and biological evaluation

  2020cites this paper
• Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA/B) inhibitors: Synthesis, biological evaluation and in silico insights.

  2020cites this paper
• Cytotoxicity and reactivity of a redox active 1,4-quinone-pyrazole compound and its Ru(II)-p-cymene complex

  2020cites this paper
• Synthesis of novel 1,2-bis-quinolinyl-1,4-naphthoquinones: Targeting by ERK2, cytotoxicity and molecular docking

  2020cites this paper
• Synthesis of quinone-based heterocycles of broad-spectrum anticancer activity

  2020cites this paper
• SYNTHETIC AND BIOLOGICAL UTILITY OF 2,3-DICHLORO-1,4-NAPHTHOQUINONE: A REVIEW

  2020cites this paper
• Synthesis and biological evaluation of novel 3-(quinolin-4-ylamino)benzenesulfonamides as carbonic anhydrase isoforms I and II inhibitors

  2019cites this paper
• Design, synthesis, and biological activity of Plastoquinone analogs as a new class of anticancer agents.

  2019cites this paper
• Synthesis, Characterization and In-vitro Evaluation of Novel Naphthoquinone Derivatives and Related Imines: Identification of New Anticancer Leads

  2019cites this paper
• Discovery and structure–activity relationship of plastoquinone analogs as anticancer agents against chronic myelogenous leukemia cells

  2019cites this paper
• A novel series of chlorinated plastoquinone analogs: Design, synthesis, and evaluation of anticancer activity

  2019cites this paper
• THE DEVELOPMENT OF NOVEL NON-PEPTIDE PROTEASOME INHIBITORS FOR THE TREATMENT OF SOLID TUMORS

  2018cites this paper
• Targeting Protein-Protein Interactions in the Ubiquitin-Proteasome Pathway.

  2018cites this paper
• Metal-free, base promoted sp2 C-H functionalization in the sulfonamidation of 1,4-naphthoquinones.

  2018cites this paper
• Synthesis of novel 1,2-bis-quinolinyl-1,4-naphthoquinones: ERK2 inhibition, cytotoxicity and molecular docking studies.

  2018cites this paper
• Next‐generation proteasome inhibitors for cancer therapy

  2018cites this paper
• Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytes

  2017cites this paper
• Synthesis, Characterization and Antibacterial Studies of N-(Benzothiazol-2-yl)-4-chlorobenzenesulphonamide and Its Neodymium(III) and Thallium(III) Complexes

  2017influential citation
• Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors

  2017cites this paper
• C-H Trifluoromethylation of 2-Substituted/Unsubstituted Aminonaphthoquinones at Room Temperature with Bench-Stable (CF3SO2)2Zn: Synthesis and Antiproliferative Evaluation.

  2017cites this paper
• Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors.

  2017cites this paper
• Diels-Alder reactions of fused 5-, 6- and 7-membered ring 2-vinylindoles: Synthesis of annulated tetrahydrocarbazoles

  2017cites this paper
• Synthesis and antiproteasomal activity of novel O-benzyl salicylamide-based inhibitors built from leucine and phenylalanine.

  2017cites this paper
• Naphthoquinone based chemosensors for transition metal ions: experiment and theory

  2017cites this paper
• Synthesis of Quinone‐Based N‐Sulfonyl‐1,2,3‐triazoles: Chemical Reactivity of Rh(II) Azavinyl Carbenes and Antitumor Activity

  2017cites this paper
• Substituted quinolines as noncovalent proteasome inhibitors.

  2016cites this paper
• Synthesis and Characterization of New 2-Quinolone Sulfonamide Derivatives

  2016cites this paper
• Cu(OAc)2/I2‐Mediated Direct Sulfonylation of Benzo[d]imidazoles with Disulfides

  2016cites this paper
• Organic Synthesis in Dedicated Continuous Flow Systems: Reductions and Oxidations

  2016cites this paper
• Copper-catalyzed three-component synthesis of aminonaphthoquinone-sulfonylamidine conjugates and in vitro evaluation of their antiproliferative activity.

  2016cites this paper
• Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors

  2015cites this paper
• Understanding cancer and the anticancer activities of naphthoquinones – a review

  2015cites this paper
• Synthesis and In Vitro Biological Evaluation of Aminonaphthoquinones and Benzo[b]phenazine-6,11-dione Derivatives as Potential Antibacterial and Antifungal Compounds

  2015cites this paper
• Discovery and Characterization of Novel Proteasome Ligand Binding Sites

  2014cites this paper
• Synthesis, anticancer activity and QSAR study of 1,4-naphthoquinone derivatives.

  2014cites this paper
• Aktywność biologiczna i metody syntezy sulfonamidów (przegląd literaturowy)

  2014cites this paper
• Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors.

  2014cites this paper
• Synthesis and methemoglobinemia-inducing properties of analogues of para-aminopropiophenone designed as humane rodenticides.

  2013cites this paper
• Oxadiazole-isopropylamides as potent and noncovalent proteasome inhibitors.

  2013cites this paper
• Why bortezomib cannot go with ‘green’?

  2013cites this paper
• Synthesis of a New Series of Quinolinoxymethylcoumarins as Potent Anticancer Agents

  2013cites this paper
• Recent advances in proteasome inhibitor discovery

  2013cites this paper
• Design and synthesis of naphthoquinone derivatives as antiproliferative agents and 20S proteasome inhibitors.

  2012cites this paper
• Combined Three Dimensional Quantitative Structure Activity Relationships (3D-QSAR) Modeling and Molecular Docking Studies on Naphthoquinone Analogs as Proteasome Inhibitors

  2012influential citation
• Covalent and non-covalent reversible proteasome inhibition

  2012cites this paper
• Discovery and synthesis of hydronaphthoquinones as novel proteasome inhibitors.

  2012cites this paper
• Use and Development of Computational Tools in Drug Discovery: From Small Molecules to Cyclic Peptides

  2012cites this paper
• Psoralenquinones as a Novel Class of Proteasome Inhibitors: Design, Synthesis and Biological Evaluation

  2011cites this paper
• The ubiquitin–proteasome system and assays to determine responses to inhibitors

  2010cites this paper
• DNA binding and biological investigations of Co(II), Cu(II) and Zn(II) metal complexes of N2O2 donor ligand derived from L-histidine and 1,4-naphthaquinone

  year unknowncites this paper